BackTable / Innovation / Podcast / Episode #60
Innovating Under Pressure: Dr. Mehdi Rezavi’s Answer to Groin Complications
with Dr. Mehdi Rezavi
In this episode, Dr. Aaron Fritts interviews Dr. Mehdi Razavi about his journey to entrepreneurship and in developing Saranas Early Bird, a vascular device that allows for early detection of perioperative bleeding.
BackTable, LLC (Producer). (2023, September 22). Ep. 60 – Innovating Under Pressure: Dr. Mehdi Rezavi’s Answer to Groin Complications [Audio podcast]. Retrieved from https://www.backtable.com
Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs. Follow the button below to claim your credits on CMEfy.
Stay Up To Date
Dr. Mehdi Rezavi
Dr. Mehdi Rezavi is the Director Clinical Arrhythmia Research and Innovations at the Texas Heart Institute and a founder of multiple biomedical companies.
Dr. Aaron Fritts
Dr. Aaron Fritts is a Co-Founder of BackTable and a practicing interventional radiologist in Dallas, Texas.
Before venturing into entrepreneurship, Mehdi was a dedicated EP cardiologist with limited exposure to entrepreneurship. After his fellowship, Mehdi took part in a Medtronic project. This experience energized him and ignited a desire to explore more opportunities for entrepreneurship.
Mehdi conceived the idea for Early Bird when he suspected a hematoma in one of his patients following an atrial ablation procedure. Recognizing the risk of postoperative bleeding in such procedures, he envisioned a solution for early hematoma detection. The device that he developed is a specialized venous axis sheath equipped with ringed electrodes. These electrodes continuously emit sub-physiologic electrical signals both throughout and after a medical procedure, enabling real-time monitoring of the sheath's impedance or resistance. This technology can detect a drop in impedance, indicating potential bleeding, as blood exhibits the lowest impedance in the body. Because their technology works as a warning system, Mehdi and his co-founder Alex Arevalos decided to name their company after the early bird genus, Serenus.
Despite working for 5-6 years to secure a patent for the idea, Mehdi remained persistent in his preclinical studies, understanding the significant impact his innovation could have on his medical specialty and the potential benefit for patients. For physicians transitioning into entrepreneurship, Mehdi suggests initiating the process of establishing a company early on to introduce more organization and delegate specific roles effectively, which allows for more time to continue working as a clinician.
Saranas Early Bird:
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.